Literature DB >> 11989739

Biofilm bacteria: formation and comparative susceptibility to antibiotics.

Merle E Olson1, Howard Ceri, Douglas W Morck, Andre G Buret, Ronald R Read.   

Abstract

The Calgary Biofilm Device (CBD) was used to form bacterial biofilms of selected veterinary gram-negative and gram-positive pathogenic bacteria from cattle, sheep, pigs, chicken, and turkeys. The minimum inhibitory concentration (MIC) and minimum biofilm eradication concentration (MBEC) of ampicillin, ceftiofur, cloxacillin, oxytetracycline, penicillin G, streptomycin, tetracycline, enrofloxacin, erythromycin, gentamicin, tilmicosin, and trimethoprim-sulfadoxine for gram-positive and -negative bacteria were determined. Bacterial biofilms were readily formed on the CBD under selected conditions. The biofilms consisted of micro-colonies encased in extracellular polysaccharide material. Biofilms composed of Arcanobacterium (Actinomyces) pyogenes, Staphylococcus aureus, Staphylococcus hyicus, Streptococcus agalactiae, Corynebacterium renale, or Corynebacterium pseudotuberculosis were not killed by the antibiotics tested but as planktonic bacteria they were sensitive at low concentrations. Biofilm and planktonic Streptococcus dysgalactiae and Streptococcus suis were sensitive to penicillin, ceftiofur, cloxacillin, ampicillin, and oxytetracycline. Planktonic Escherichia coli were sensitive to enrofloxacin, gentamicin, oxytetracycline and trimethoprim/ sulfadoxine. Enrofloxacin and gentamicin were the most effective antibiotics against E. coli growing as a biofilm. Salmonella spp. and Pseudomonas aeruginosa isolates growing as planktonic populations were sensitive to enrofloxacin, gentamicin, ampicillin, oxytetracycline, and trimethoprim/sulfadoxine, but as a biofilm, these bacteria were only sensitive to enrofloxacin. Planktonic and biofilm Pasteurella multocida and Mannheimia haemolytica had similar antibiotic sensitivity profiles and were sensitive to most of the antibiotics tested. The CBD provides a valuable new technology that can be used to select antibiotics that are able to kill bacteria growing as biofilms.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11989739      PMCID: PMC226988     

Source DB:  PubMed          Journal:  Can J Vet Res        ISSN: 0830-9000            Impact factor:   1.310


  17 in total

Review 1.  Genetic analyses of bacterial biofilm formation.

Authors:  L A Pratt; R Kolter
Journal:  Curr Opin Microbiol       Date:  1999-12       Impact factor: 7.934

Review 2.  Bacterial biofilms: a common cause of persistent infections.

Authors:  J W Costerton; P S Stewart; E P Greenberg
Journal:  Science       Date:  1999-05-21       Impact factor: 47.728

3.  Forging a link between biofilms and disease.

Authors:  C Potera
Journal:  Science       Date:  1999-03-19       Impact factor: 47.728

4.  Method of evaluating effects of antibiotics on bacterial biofilm.

Authors:  B L Prosser; D Taylor; B A Dix; R Cleeland
Journal:  Antimicrob Agents Chemother       Date:  1987-10       Impact factor: 5.191

5.  Antimicrobial susceptibility testing and antimicrobial drug dosage.

Authors:  J F Prescott; J D Baggot
Journal:  J Am Vet Med Assoc       Date:  1985-08-15       Impact factor: 1.936

6.  Comparison of success of antibiotic therapy during lactation and results of antimicrobial susceptibility tests for bovine mastitis.

Authors:  W E Owens; C H Ray; J L Watts; R J Yancey
Journal:  J Dairy Sci       Date:  1997-02       Impact factor: 4.034

7.  Presence of bacterial glycocalyx and fimbriae on Pasteurella haemolytica in feedlot cattle with pneumonic pasteurellosis.

Authors:  D W Morck; M E Olson; S D Acres; P Y Daoust; J W Costerton
Journal:  Can J Vet Res       Date:  1989-04       Impact factor: 1.310

8.  Phase variation of slime production in Staphylococcus aureus: implications in colonization and virulence.

Authors:  R Baselga; I Albizu; M De La Cruz; E Del Cacho; M Barberan; B Amorena
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

9.  Comparative evaluation of fleroxacin, ampicillin, trimethoprimsulfamethoxazole, and gentamicin as treatments of catheter-associated urinary tract infection in a rabbit model.

Authors:  D W Morck; K Lam; S G McKay; M E Olson; B Prosser; B D Ellis; R Cleeland; J W Costerton
Journal:  Int J Antimicrob Agents       Date:  1994-07       Impact factor: 5.283

10.  Tobramycin resistance of Pseudomonas aeruginosa cells growing as a biofilm on urinary catheter material.

Authors:  J C Nickel; I Ruseska; J B Wright; J W Costerton
Journal:  Antimicrob Agents Chemother       Date:  1985-04       Impact factor: 5.191

View more
  148 in total

Review 1.  A critical review of modern and emerging absorbent dressings used to treat exuding wounds.

Authors:  India R Sweeney; Mohsen Miraftab; Graham Collyer
Journal:  Int Wound J       Date:  2012-01-17       Impact factor: 3.315

2.  Targeted delivery of vancomycin to Staphylococcus epidermidis biofilms using a fibrinogen-derived peptide.

Authors:  Christopher M Hofmann; James M Anderson; Roger E Marchant
Journal:  J Biomed Mater Res A       Date:  2012-05-24       Impact factor: 4.396

3.  Comparative antimicrobial susceptibility of biofilm versus planktonic forms of Salmonella enterica strains isolated from children with gastroenteritis.

Authors:  K Papavasileiou; E Papavasileiou; A Tseleni-Kotsovili; S Bersimis; C Nicolaou; A Ioannidis; S Chatzipanagiotou
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-07-18       Impact factor: 3.267

4.  CORR Insights(®): D-amino acid inhibits biofilm but not new bone formation in an ovine model.

Authors:  Jessica Amber Jennings
Journal:  Clin Orthop Relat Res       Date:  2015-08-27       Impact factor: 4.176

5.  Hypothetical protein Avin_16040 as the S-layer protein of Azotobacter vinelandii and its involvement in plant root surface attachment.

Authors:  Pauline Woan Ying Liew; Bor Chyan Jong; Nazalan Najimudin
Journal:  Appl Environ Microbiol       Date:  2015-08-14       Impact factor: 4.792

6.  Increased antibiotic resistance of Escherichia coli in mature biofilms.

Authors:  Akinobu Ito; Asami Taniuchi; Thithiwat May; Koji Kawata; Satoshi Okabe
Journal:  Appl Environ Microbiol       Date:  2009-04-17       Impact factor: 4.792

7.  Non-invasive imaging of oxygen concentration in a complex in vitro biofilm infection model using 19 F MRI: Persistence of an oxygen sink despite prolonged antibiotic therapy.

Authors:  Jeffrey W Simkins; Philip S Stewart; Sarah L Codd; Joseph D Seymour
Journal:  Magn Reson Med       Date:  2019-08-02       Impact factor: 4.668

8.  Silver oxynitrate, an unexplored silver compound with antimicrobial and antibiofilm activity.

Authors:  Joe A Lemire; Lindsay Kalan; Alexandru Bradu; Raymond J Turner
Journal:  Antimicrob Agents Chemother       Date:  2015-04-27       Impact factor: 5.191

9.  Catheter-related Corynebacterium bacteremia: should the catheter be removed and vancomycin administered?

Authors:  S Ghide; Y Jiang; R Hachem; A-M Chaftari; I Raad
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-12-17       Impact factor: 3.267

10.  Antibiotic-loaded phosphatidylcholine inhibits staphylococcal bone infection.

Authors:  Jessica Amber Jennings; Karen E Beenken; Robert A Skinner; Daniel G Meeker; Mark S Smeltzer; Warren O Haggard; Karen S Troxel
Journal:  World J Orthop       Date:  2016-08-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.